Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer

被引:182
|
作者
Wheeler, TM
Dillioglugil, O
Kattan, MW
Arakawa, A
Soh, S
Suyama, K
Ohori, M
Scardino, PT
机构
[1] Baylor Coll Med, Dept Pathol, Scott Dept Urol, Houston, TX 77030 USA
[2] Baylor Coll Med, Matsunaga Conte Prostate Canc Res Ctr, Houston, TX 77030 USA
[3] Baylor Coll Med, Informat Technol Program, Houston, TX 77030 USA
[4] Methodist Hosp, Houston, TX 77030 USA
关键词
prostatic neoplasms; prostatectomy; extraprostatic extension; prostatic capsular invasion; prostate cancer recurrence;
D O I
10.1016/S0046-8177(98)90457-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This study was performed to assess the relationship between the level and extent of prostatic capsular invasion (PCI) by cancer and the clinical and pathological features and prognosis of early-stage prostate cancer. We conducted a retrospective analysis of the clinical (age, stage, grade, prostate specific antigen [PSA] level) and pathological (tumor volume, stage, grade, surgical margins) features of 688 patients treated with radical prostatectomy to determine the pathological features and probability of recurrence associated with various levels of PCI. Radical prostatectomy specimens were serially sectioned and examined by whole-mount technique. Progression-free probabilities (PFP) after radical prostatectomy were determined by Kaplan-Meier and Cox proportional hazards regression analysis. Progression was defined as a rising serum PSA greater than or equal to 0.4 ng/mL or clinical evidence of recurrent cancer. Increasing clinical stage, Gleason grade in the biopsy specimen, and pretreatment serum PSA levels were each associated with increasing levels of PCI (P < .001). In the radical prostatectomy specimen, increasing levels of PCI were significantly associated with increasing tumor volume (P < .001), Gleason grade (P < .0001), seminal vesicle involvement (SVI, P < .001) and lymph node metastases (+LN, P < .001). None of 138 patients without capsular invasion had SVI or lymph node metastases (+LN), and all remained free of progression, even though some had large volume (up to 6.26 cm(3)) or poorly differentiated (Gleason sum up to 8) cancers. Invasion into the capsule (n = 271) was occasionally associated with SM (6%) or +LN (3%) and a significantly (log-rank test) lower PFP of 87% at 5 years. Focal and extensive extraprostatic extension (EPE) were associated with progressively increased risk of SVI and +LN and lower PFP (73% and 42%, respectively). In a multivariate analysis, the level of PCI was an independent prognostic factor (P < .001). There is a strong association between the level of invasion of cancer into or through the prostatic capsule and the volume, grade, pathological stage, and rate of recurrence after radical prostatectomy. Prostate cancer does not appear to metastasize in the absence of invasion into the capsule regardless of the volume or grade of the intracapsular tumor. Subclassification of patients according to the levels of PCI provides valuable prognostic information. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:856 / 862
页数:7
相关论文
共 50 条
  • [21] Deep learning radiomics for prediction of axillary lymph node metastasis in patients with clinical stage T1-2 breast cancer
    Wei, Wei
    Ma, Qiang
    Feng, Huijun
    Wei, Tianjun
    Jiang, Feng
    Fan, Lifang
    Zhang, Wei
    Xu, Jingya
    Zhang, Xia
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (08) : 4995 - +
  • [22] Clinical significance of pulmonary metastases in stage D2 prostate cancer patients
    H Nakamachi
    H Suzuki
    K Akakura
    T Imamoto
    T Ueda
    M Ishihara
    Y Furuya
    T Ichikawa
    T Igarashi
    H Ito
    Prostate Cancer and Prostatic Diseases, 2002, 5 : 159 - 163
  • [23] Clinical significance of pulmonary metastases in stage D2 prostate cancer patients
    Nakamachi, H
    Suzuki, H
    Akakura, K
    Imamoto, T
    Ueda, T
    Ishihara, M
    Furuya, Y
    Ichikawa, T
    Igarashi, T
    Ito, H
    PROSTATE CANCER AND PROSTATIC DISEASES, 2002, 5 (02) : 159 - 163
  • [24] How does age, PSA level and DIRE clinical stage correlate with pathological stage of prostate cancer in a New Zealand population?
    Leslie, S.
    BJU INTERNATIONAL, 2008, 101 : 31 - 31
  • [25] The Clinical Significance of Perineural Invasion by Prostate Cancer on MRI-Targeted Biopsy
    Suresh, Nivedita
    Teramoto, Yuki
    Goto, Takuro
    Wang, Ying
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 618 - 619
  • [26] The clinical significance of perineural invasion in patients with de novo metastatic prostate cancer
    Zhao, J.
    Chen, J.
    Zhang, M.
    Tang, X.
    Sun, G.
    Zhu, S.
    Liu, J.
    Zhang, H.
    Zhang, X.
    Yin, X.
    Zhao, P.
    Zhu, X.
    Ni, Y.
    Dai, J.
    Shen, P.
    Chen, N.
    Zeng, H.
    ANDROLOGY, 2019, 7 (02) : 184 - 192
  • [27] The Clinical Significance of Perineural Invasion by Prostate Cancer on MRI-Targeted Biopsy
    Suresh, Nivedita
    Teramoto, Yuki
    Goto, Takuro
    Wang, Ying
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 618 - 619
  • [28] Prognostic Significance of Vas Deferens Invasion After Radical Prostatectomy in Patients with Pathological Stage T3b Prostate Cancer
    Jang, Won Sik
    Yoon, Cheol Yong
    Kim, Ki Hong
    Kang, Yong Jin
    Shin, Su-Jin
    Cho, Nam Hoon
    Lee, Joo Yong
    Cho, Kang Su
    Ham, Won Sik
    Rha, Koon Ho
    Hong, Sung Joon
    Choi, Young Deuk
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (04) : 1143 - 1149
  • [29] Prognostic Significance of Vas Deferens Invasion After Radical Prostatectomy in Patients with Pathological Stage T3b Prostate Cancer
    Won Sik Jang
    Cheol Yong Yoon
    Ki Hong Kim
    Yong Jin Kang
    Su-Jin Shin
    Nam Hoon Cho
    Joo Yong Lee
    Kang Su Cho
    Won Sik Ham
    Koon Ho Rha
    Sung Joon Hong
    Young Deuk Choi
    Annals of Surgical Oncology, 2017, 24 : 1143 - 1149
  • [30] Evaluation of Clinical Significance of Lymphovascular Space Invasion in Stage IA Endometrial Cancer
    Okugawa, Kaoru
    Yahata, Hideaki
    Hachisuga, Kazuhisa
    Tomonobe, Hiroshi
    Yasutake, Nobuko
    Kodama, Keisuke
    Kenjo, Hironori
    Yagi, Hiroshi
    Ohgami, Tatsuhiro
    Yasunaga, Masafumi
    Onoyama, Ichiro
    Asanoma, Kazuo
    Hori, Emiko
    Ohishi, Yoshihiro
    Oda, Yoshinao
    Kato, Kiyoko
    ONCOLOGY, 2022, 100 (04) : 195 - 202